1. Correlation of MAGE-A tumor antigens and the efficacy of various chemotherapeutic agents in head and neck carcinoma cells
   S. Hartmann et al, 2014, Clin Oral Invest CrossRef
2. Erlotinib and gefitinib responsiveness in head and neck cancer cell lines—a comparing analysis with cetuximab
   Stefan Hartmann et al, 2016, Clin Oral Invest CrossRef
3. Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma
   M. BRISAM et al, 2016 CrossRef
4. MAGE-A1–6   expression in patients with head and neck squamous cell carcinoma: impact on clinical patterns and oncologic outcomes
   Sang Tae Noh et al, 2016, Int J Clin Oncol CrossRef
5. Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer
   Adviti Naik et al, 2024, Molecular Therapy: Oncology CrossRef